ONW
ONWARD Medical
Stock
Stock
ISIN: NL0015000HT4
Ticker: ONWD
NL0015000HT4
ONWD
Price
Price
CHART BY
Frequently asked questions
What is ONWARD Medical's market capitalization?
The market capitalization of ONWARD Medical is 194.21M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for ONWARD Medical?
ONWARD Medical's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.919. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for ONWARD Medical's stock?
Currently, 3 analysts cover ONWARD Medical's stock, with a consensus target price of 13.53. Analyst ratings provide insights into the stock's expected performance.
What is ONWARD Medical's revenue over the trailing twelve months?
Over the trailing twelve months, ONWARD Medical reported a revenue of 77.00K.
What is the EBITDA for ONWARD Medical?
ONWARD Medical's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -35.63M. EBITDA measures the company's overall financial performance.
What is the free cash flow of ONWARD Medical?
ONWARD Medical has a free cash flow of -31.91M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of ONWARD Medical's shares?
The free float of ONWARD Medical is 32.30M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 194.21M
- EPS (TTM)
- -$0.919
- Free Float
- 32.30M
- Revenue (TTM)
- 77.00K
- EBITDA (TTM)
- -35.63M
- Free Cashflow (TTM)
- -31.91M
Pricing
- 1D span
- $5.129$5.549
- 52W span
- $3.812$7.545
Analyst Ratings
The price target is 13.53 and the stock is covered by 3 analysts.
Buy
3
Hold
0
Sell
0
Information
Onward Medical NV is a medical technology company, which engages in creating therapies to restore movement, independence, and health in people with spinal cord injury. Its technology platforms are based on ARC Therapy targeted, programmed electrical stimulation of the spinal cord designed to restore movement independence, and health in people with SCI. The company was founded by Grégoire Courtine, Vincent Delattre and Jocelyn Bloch in 2014 and is headquartered in Eindhoven, the Netherlands.
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- NL0015000HT4
- Primary Ticker
- ONWD
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet